Deutsche Nationalbibliothekmetadata only
Efficacy and safety of nemolizumab at week 48: results from the maintenance phase of two global phase 3 pivotal studies (ARCADIA 1&2) in patients with moderate-to-severe atopic dermatitis / Andreas Wollenberg, Jonathan I. Silverberg, Franz J. Legat, Marie Tauber, Vivian T. Laquer, April W. Armstrong, Andrew E. Pink, Luigi Naldi, Grazyna Pulka, Jacek Zdybski, Athanasios Tsianakas, Jorge Diaz, Inese Svarca, Jennifer Beecker, Galina Balakirski, Sylvia Pauser, Liliana Ulianov, Anna Ryzhkova, Jean-Loup Machu, Christophe Piketty
610 medizin, gesundheit
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 783961
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.